MAP3K5 and early-onset autosomal dominant Alzheimer disease: Additionally, AST4 expressed a high level of MAP3K5, MAPK10, and TUBB3, which are enriched in Alzheimer's disease–related pathways (hsa05010, P = 2.0 × 10−07) (Fig. 3D) [54, 55].